Finding 1092010 (2023-009)

Significant Deficiency Repeat Finding
Requirement
B
Questioned Costs
-
Year
2023
Accepted
2024-12-18
Audit: 333283
Organization: Unity Health Care, Inc. (MD)
Auditor: Bdo USA PC

AI Summary

  • Core Issue: The Corporation lacks proper documentation for indirect cost pools, impacting compliance with Federal regulations.
  • Impacted Requirements: Failure to adhere to 2 CFR 200.303(a) and Appendix IV to Part 200 Section B.2(b) regarding the allowability of indirect costs.
  • Recommended Follow-up: Establish formal processes and policies to ensure compliance with indirect cost allowability requirements.

Finding Text

Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the Federal award that provides assurance that the entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. Additionally, 2 CFR Appendix IV to Part 200 Section B.2(b) requires that both the direct costs and the indirect costs must exclude capital expenditures and unallowable costs. Per Compliance Supplement, these indirect costs must conform to the allowability of cost provisions in 2 CFR Part 200, Subpart E or award agreement. Condition: During our testing of indirect costs, we noted that the Corporation charges the Federally approved rate of 28.7% on specific grant awards based on direct salaries and wages. However, the Corporation did not maintain supporting indirect cost pools and related documentation. Cause: The Corporation did not have formal process and policies to demonstrate adherence to the allowability requirements of indirect costs in accordance with 2 CFR Appendix IV to Part 200 Section B.2(b). Effect or Potential Effect: We were unable to determine whether indirect costs charged to Federal awards conform to the allowability of cost provisions in 2 CFR Part 200, Subpart E or award agreement. Allowable costs incurred by the Corporation exceeded the amount of approved grant funding, therefore no questioned costs are reported. Questioned costs: Unknown Context: Management was not able to provide sufficient and appropriate evidence that the reported indirect costs conformed to the allowability of cost provisions in 2 CFR Part 200, Subpart E or award agreement. Repeat finding: This is a repeat finding from prior year. This was reported as finding 2022-016 in the 2022 report. Recommendation: We recommend the Corporation develop and incorporate internal controls and policies to demonstrate adherence to the allowability requirements of indirect costs in accordance with 2 CFR Appendix IV to Part 200 Section B.2(b). View of Responsible Officials: Due to turnover of several key financial executives and personnel, the Corporation did not maintain any supporting indirect cost pools and related documentation.

Categories

Allowable Costs / Cost Principles

Other Findings in this Audit

  • 515547 2023-004
    Material Weakness Repeat
  • 515548 2023-005
    Material Weakness Repeat
  • 515549 2023-006
    Material Weakness Repeat
  • 515550 2023-007
    Significant Deficiency Repeat
  • 515551 2023-004
    Material Weakness Repeat
  • 515552 2023-005
    Material Weakness Repeat
  • 515553 2023-006
    Material Weakness Repeat
  • 515554 2023-007
    Significant Deficiency Repeat
  • 515555 2023-004
    Material Weakness Repeat
  • 515556 2023-005
    Material Weakness Repeat
  • 515557 2023-006
    Material Weakness Repeat
  • 515558 2023-009
    Significant Deficiency Repeat
  • 515559 2023-004
    Material Weakness
  • 515560 2023-007
    Significant Deficiency
  • 515561 2023-004
    Material Weakness Repeat
  • 515562 2023-005
    Material Weakness Repeat
  • 515563 2023-006
    Material Weakness Repeat
  • 515564 2023-009
    Significant Deficiency Repeat
  • 515565 2023-004
    Material Weakness Repeat
  • 515566 2023-005
    Material Weakness Repeat
  • 515567 2023-006
    Material Weakness Repeat
  • 515568 2023-009
    Significant Deficiency Repeat
  • 515569 2023-004
    Material Weakness Repeat
  • 515570 2023-005
    Material Weakness Repeat
  • 515571 2023-006
    Material Weakness Repeat
  • 515572 2023-007
    Significant Deficiency Repeat
  • 515573 2023-008
    Significant Deficiency Repeat
  • 515574 2023-009
    Significant Deficiency Repeat
  • 1091989 2023-004
    Material Weakness Repeat
  • 1091990 2023-005
    Material Weakness Repeat
  • 1091991 2023-006
    Material Weakness Repeat
  • 1091992 2023-007
    Significant Deficiency Repeat
  • 1091993 2023-004
    Material Weakness Repeat
  • 1091994 2023-005
    Material Weakness Repeat
  • 1091995 2023-006
    Material Weakness Repeat
  • 1091996 2023-007
    Significant Deficiency Repeat
  • 1091997 2023-004
    Material Weakness Repeat
  • 1091998 2023-005
    Material Weakness Repeat
  • 1091999 2023-006
    Material Weakness Repeat
  • 1092000 2023-009
    Significant Deficiency Repeat
  • 1092001 2023-004
    Material Weakness
  • 1092002 2023-007
    Significant Deficiency
  • 1092003 2023-004
    Material Weakness Repeat
  • 1092004 2023-005
    Material Weakness Repeat
  • 1092005 2023-006
    Material Weakness Repeat
  • 1092006 2023-009
    Significant Deficiency Repeat
  • 1092007 2023-004
    Material Weakness Repeat
  • 1092008 2023-005
    Material Weakness Repeat
  • 1092009 2023-006
    Material Weakness Repeat
  • 1092011 2023-004
    Material Weakness Repeat
  • 1092012 2023-005
    Material Weakness Repeat
  • 1092013 2023-006
    Material Weakness Repeat
  • 1092014 2023-007
    Significant Deficiency Repeat
  • 1092015 2023-008
    Significant Deficiency Repeat
  • 1092016 2023-009
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
10.557 Wic Special Supplemental Nutrition Program for Women, Infants, and Children $5.29M
93.224 Community Health Centers $2.85M
93.788 Opioid Str $2.05M
93.217 Family Planning Services $1.47M
93.914 Hiv Emergency Relief Project Grants $1.34M
93.526 Fip Verification $898,419
93.527 Affordable Care Act (aca) Grants for New and Expanded Services Under the Health Center Program $862,759
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $459,480
93.837 Cardiovascular Diseases Research $410,473
93.917 Hiv Care Formula Grants $409,149
93.994 Maternal and Child Health Services Block Grant to the States $328,090
93.427 Provision of Technical Assistance and Training Activities to Assure Comprehensive Cancer Control Outcomes. $113,387
93.426 The National Cardiovascular Health Program $102,468
93.898 Cancer Prevention and Control Programs for State, Territorial and Tribal Organizations $102,041
93.855 Allergy and Infectious Diseases Research $7,112